PRAX Q2 2022 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena

PRAXPraxis Precision Medicines, Inc.

$7B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$3M

Operating Income

-$60M

Net Income

-$60M

EPS (Diluted)

$-19.76

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$57M

Free Cash Flow

-$57M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$180M

Total Liabilities

$42M

Stockholders' Equity

$139M

Cash & Equivalents

$56M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$3M	$0	—
Operating Income	-$60M	-$36M	-65.5%
Net Income	-$60M	-$36M	-65.4%